methacycline has been researched along with prazosin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, H; Ito, T; Kawai, T; Okumura, K; Satake, T | 1 |
| Jeanrenaud, B; Proietto, J; van de Werve, G | 1 |
| Kurz, T; Richardt, G; Schneider, I; Tölg, R | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
4 other study(ies) available for methacycline and prazosin
| Article | Year |
|---|---|
Alteration of 1,2-diacylglycerol content in ischemic and reperfused heart.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Diglycerides; Dogs; Kinetics; Male; Myocardial Reperfusion; Myocardium; Phospholipids; Prazosin | 1990 |
Control of glycogen phosphorylase interconversion by phorbol esters, diacylglycerols, Ca2+ and hormones in isolated rat hepatocytes.
Topics: Animals; Calcimycin; Calcium; Diglycerides; Drug Synergism; Enzyme Activation; Glycerides; Hormones; In Vitro Techniques; Liver; Male; Phenylephrine; Phorbol Esters; Phosphorylases; Prazosin; Protein Kinase C; Rats; Rats, Inbred Strains | 1985 |
Alpha 1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Chromatography, Thin Layer; Desipramine; Diacylglycerol Kinase; Diglycerides; Estrenes; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Norepinephrine; Perfusion; Phosphatidic Acids; Piperidines; Prazosin; Propranolol; Pyrrolidinones; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Time Factors; Type C Phospholipases | 1999 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |